Newswise — Kevin J. Cullen, MD, Michael B. Kastan, MD, PhD, and Edison T. Liu, MD, have been elected to the board of directors of the Association of American Cancer Institutes.
Dr. Cullen is director of the University of Maryland Marlene and Stewart Greenebaum Cancer Center. He specializes in head and neck cancer, is a professor of medicine at the University of Maryland School of Medicine and is head of its program in oncology.
Dr. Kastan has served as executive director of the Duke Cancer Institute since 2011. He is a pediatric oncologist and a cancer biologist and his laboratory research concentrates on DNA damage and repair, tumor suppressor genes, and causes of cancer related to genetic predisposition and environmental exposures.
Dr. Liu is the president and CEO of The Jackson Laboratory and director of The Jackson Laboratory Cancer Center, and has been president of the international Human Genome Organization since 2007. Dr. Liu joined the Jackson Laboratory from the Genome Institute of Singapore.
The directors’ three-year terms will commence on October 14 during the AACI/CCAF annual meeting. AACI and the Cancer Center Administrators Forum (CCAF) jointly formulated the program for the meeting, which will be held October 14-16 at The Westin Chicago River North, Chicago. More information on the meeting, including the program and electronic registration, is available at AACI’s website, www.aaci-cancer.org.
###
Representing 95 of the nation’s premier academic and free-standing cancer research centers, the Association of American Cancer Institutes is dedicated to promoting leading research institutions' efforts to eradicate cancer through a comprehensive and multidisciplinary program of cancer research, treatment, patient care, prevention, education and community outreach.
RSS